Neil Gallagher - 02 Apr 2024 Form 3 Insider Report for Zymeworks Inc. (ZYME)

Reporting relationship
Director
Issuer ticker
ZYME
Reported as of
02 Apr 2024
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
02 Apr 2024, 21:52:46 UTC
Prior SEC filing
09 Feb 2024
Next SEC filing
12 Dec 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel Dex, Attorney-in-Fact

Key filing fact

Neil Gallagher filed Form 3 for Zymeworks Inc. (ZYME) on 02 Apr 2024.

Key facts

  • This page summarizes Neil Gallagher's Form 3 filing for Zymeworks Inc. (ZYME).
  • 0 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 02 Apr 2024, 21:52.

Change

  • Previous filing in this sequence was filed on 09 Feb 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZYME holding

No securities are beneficially owned

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
0
Date
02 Apr 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZYME holding Derivative

No securities are beneficially owned

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
02 Apr 2024
Ownership
Direct
Underlying class
Not applicable
Underlying amount
0
Exercise price
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Not applicable.

SEC remarks

Exhibit List - Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .